financial results of 2017 2nd quarterfinancial results of 2017 2q (2) numerical plan net sales and...

Financial Results of 2017 2nd Quarter

(Code 3001, TSE 1st section)

August 21, 2017

Financial Results of 2017 2QContents

2

１．Financial Highlights of 2017 2nd Quarter

Consolidated Income Statement

Consolidated Income Statement / Business Segment

Consolidated Balance Sheet

Consolidated Statement of Cash Flows

２．2017 Forecast

Consolidated Income Statement / Forecast

Consolidated Income Statement / Business Segment Forecast

Capital Expenditures, Depreciation and R&D Expenditures Forecast

３．Progress Report on “Katakura 2021”

４．Dividends and Dividend Policy

１．Financial Highlights of 2017 2nd Quarter

3

Financial Results of 2017 2QConsolidated Income Statement

4

Machinery sales increased, and pharmaceuticals and real estate earnings rose. Net sales were lower than forecast, but earnings increased on delayed recording of costs

【 Net sales 】・ Machinery :Up ¥1,000mn・ Pharmaceuticals : Down ¥300mn・ Textiles : Down ¥200mn

【 Operating income 】・ Pharmaceuticals : Up ¥300mn・ Real Estate : Up ¥200mn・ adjustments : Down ¥200mn

【 Profit attributable to owners of parent 】

・ Earnings down due to gains on sales of investment securities (1 billion yen) was recorded in 2016

【 Net sales 】・ Textiles: Down ¥100mn・ Machinery: Down ¥100mn・ Others: Down ¥100mn

【 Operating income 】・ Pharmaceuticals: Up ¥400mn

24,347 24,935

25,467

(282)

1,221 1,530

(1,000)

0

1,000

2,000

3,000

4,000

5,000

15,000

20,000

25,000

30,000

2015.1-6 2016.1-6 2017.1-6

Earn

ing

s

Net s

ale

s

Three-Year Summary

Net sales Operating income

（Million yen）

2017.1-6Actual 2016.1-6Actual YoY change YoY change ratio 2017.1-6ForecastActual vs.

Forecast

ＡＢ A-B A/B Ｃ A-C

Net sales 25,467 24,935 532 102% 25,800 (333)

Operating income 1,530 1,221 309 125% 1,200 330

Operating income ratio 6.0% 4.9% 1.1pt 123% 4.7% 1.4pt

Ordinary income 1,956 1,553 403 126% 1,500 456

Profit attributable to

owners of parent916 1,457 (541) 63% 700 216

Financial Results of 2017 2QConsolidated Income Statement / Business Segment

5

①： Increase in earnings in pharmaceuticals

・ Increase due to research and development expenses (R&D) being delayed to 2H

②： Earnings increase in real estate

・ Increase due to repairs and other expenses being delayed to 2H

Textiles

17.7%

Pharmaceuti

cals

29.6%Machinery

27.3%

Real Estate

20.2%

Others

4.9%

New

businesses

0.3%

Business Segment Sales①： Significant sales growth in machinery

・ Increase in sales due to growth in orders for large-size pump trucks and chemicals vehicles but only slight growth in earnings because outsourcing expenses and other manufacturing costs were also higher

②： Lower sales but increase in earnings in pharmaceuticals

・ Decrease in sales due to decline in long-term listed drugs and in core Flandol tape in particular

・ Increase in earnings due to decreases in research and development expenses (R&D) and depreciation expenses, etc.

③： Lower sales and earnings in textiles・ Strong performance by functional fibers, but

sluggish sales of casual inners resulted in lower sales and earnings

2017.1-6Actual

①②③

※

①

②

※

※： Decreased earnings due to adjusted amount

・ Due to increase in retirement benefit expenses

（Million yen）

Net sales Operating income Net sales Operating income Net sales Operating income Net sales Operating income Net sales Operating income

Textiles 4,495 (57) 4,738 (24) (243) (33) 4,600 (100) (105) 43

Pharmaceuticals 7,530 513 7,858 223 (328) 290 7,500 100 30 413

Machinery 6,960 208 5,945 184 1,015 24 7,100 350 (140) (142)

Real Estate 5,141 1,778 5,037 1,626 104 152 5,100 1,600 41 178

Others 1,260 23 1,302 19 (42) 4 1,400 50 (140) (27)

New businesses 79 (172) 54 (236) 25 64 100 (150) (21) (22)

adjustments － (764) － (571) － (193) － (650) － (114)

25,467 1,530 24,935 1,221 532 309 25,800 1,200 (333) 330

2017.1-6Forecast

Total

2017.1-6Actual 2016.1-6Actual

ＡＢ A-B

YoY change

Ｃ A-C

Actual vs. Forecast

Financial Results of 2017 2QConsolidated Balance Sheet

6

・ Reduction in inventories due to shipments of fire enginesand other items

・ Down due to valuation

difference in market value of investment securities

（Million yen）

2017.6 2016.12 YoY change

A B A-B

51,941 54,228 (2,287)

87,986 90,430 (2,444)

50,769 51,509 (740)

1,208 1,350 (142)

36,008 37,570 (1,562)

Investment securities 33,173 34,635 (1,462)

139,928 144,659 (4,731)

61,233 65,752 (4,519)

Loans 19,012 19,649 (637)

Lease and guarantee deposits 9,823 9,810 13

Deferred tax liabilities 9,953 10,294 (341)

78,694 78,906 (212)

Valuation difference on available-for-sale securities 16,049 16,349 (300)

Non-controlling interest 22,818 23,337 (519)

139,928 144,659 (4,731)Total liabilities and net assets

Total net assets

Total liabilities

Investments and other assets

Total assets

Current assets

Non-current assets

Property,plant and equipment

Intangible assets

Financial Results of 2017 2Q

13,248

11,405

8,000

10,000

12,000

14,000

16,000

18,000

beginning of year Operating CF Investing CF Financing CF end of year

Cash Flows

Consolidated Statement of Cash Flows

7

【 Operating cash flows 】

・ Profit before income taxes: Up ¥1,600mn

・ Depreciation: Up ¥1,700mn

2,854(3,468)

(1,229)

（Million yen）

2017.1-6Actual 2016.1-6Actual

13,248 9,256

Operating cash flows 2,854 4,521

Investing cash flows (3,468) (2,421)

Financing cash flows (1,229) (4,634)

(1,843) (2,534)

11,405 6,722

Cash and cash equivalents at beginning of year

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents at end of year

【 Investing cash flows 】

・ Purchase of property, plant and equipment : Down ¥700mn

・ Transfers to time deposit of 3 months and over: Down ¥2,700mn

【 Financing cash flows 】

・ Repayments of short-term loans payable: Down ¥1,100mn

・ Increase in long-term loans payable: Up ¥500mn

Financial Results of 2017 2Qmemo

8

２．2017 Forecast

9

Financial Results of 2017 2QConsolidated Income Statement / Forecast

10

【 Net sales 】・ Machinery :Up ¥900mn・ Pharmaceuticals : Down ¥400mn

【 Operating income 】・ Real Estate : Up ¥200mn・ New businesses : Up ¥200mn・ Textiles : Up ¥200mn・ adjustments : Down ¥400mn


・ Earnings down due to proceeds from sales of investment securities (¥1,200mn) in 2016

Increase in net sales and operating income compared to the previous term. Compared to initial forecast, real estate sales are favorable, but both net sales and earnings expected to decline

48,573 46,927 47,400

(190)

1,486 1,750

(300)

700

1,700

2,700

3,700

4,700

15,000

25,000

35,000

45,000

55,000

2015 2016 2017Revised Forecast

Earn

ing

s

Net s

ale

s

Three-Year Summary

Net sales Operating income

【 Net sales 】・ Pharmaceuticals : Down ¥300mn・ Others : Down ¥200mn

【 Operating income 】・ adjustments : Down ¥300mn

【 Ordinary income】・ As forecasted, due to increase in

miscellaneous income etc.


・ Decline in earnings due to loss on disposal of non-current assets

（Million yen）

2017Revised

Forecast2016Actual YoY change YoY change ratio

2017Initial

ForecastDifference

A B A-B A/C C A-C

Net sales 47,400 46,927 473 101% 48,000 (600)

Operating income 1,750 1,486 264 118% 2,000 (250)

Operating income ratio 3.7% 3.2% 0.5pt 117% 4.2% (0.5)pt

Ordinary income 2,500 2,152 348 116% 2,500 0

Profit attributable to

owners of parent1,200 1,691 (491) 71% 1,300 (100)

Financial Results of 2017 2QConsolidated Income Statement / Business Segment Forecast

11

Textiles

19.8%

Pharmaceu

ticals

31.0%

Machinery

21.7%

Real Estate

21.7%

Others

5.3%

New

businesses

0.4%

Business Segment Sales

2017RevisedForecast

①： Decline sales but earnings as forecasted in pharmaceutical

・ Decrease in sales due to decline in long-term listed drugs but earnings expected in line with initial forecast due to decrease in research and development expenses (R&D) etc.

②： Increases in sales and earnings in real estate

・ Increased earnings expected due to decrease in repair expenses, etc.

①： Significant increase in sales but decline in earnings in machinery

・ Increase in sales due to growth in orders for large-size pump trucks and chemicals vehicles but decline in earnings because outsourcing expenses and other manufacturing costs are expected to be higher

②： Decrease in sales but earnings growth in pharmaceuticals

・ Decrease due to decline in long-term listed drugs etc.

・ Increase in earnings due to decrease in research and development expenses, depreciation expenses etc.

③： Decrease in sales but improvement forecasted in textiles

・ Decrease due to sluggish sales of casual innerwear but improvement forecasted on strong performance in functional fibers

①

②③

※

①

②

※

※： Decrease in earnings due to adjusted amount

・ Due to increase in retirement benefit expenses

（Million yen）

Net sales Operating income Net sales Operating income Net sales Operating income Net sales Operating income Net sales Operating income

Textiles 9,400 (100) 9,635 (250) (235) 150 9,500 (100) (100) 0

Pharmaceuticals 14,700 300 15,065 199 (365) 101 15,000 300 (300) 0

Machinery 10,300 50 9,412 88 888 (38) 10,300 150 0 (100)

Real Estate 10,300 3,400 10,188 3,176 112 224 10,200 3,200 100 200

Others 2,500 0 2,502 (27) (2) 27 2,700 100 (200) (100)

New businesses 200 (300) 124 (484) 76 184 300 (300) (100) 0

adjustments － (1,600) － (1,216) － (384) － (1,350) － (250)

47,400 1,750 46,927 1,486 473 264 48,000 2,000 (600) (250)

2017Revised Forecast

Total

A

2016Actual YoY change 2017Initial Forecast Difference

B A-B C A-C

Financial Results of 2017 2QCapital Expenditures, Depreciation and R&D Expenditures Forecast

12

①：Resulting from the

transfer of manufacturing and sales rights of a product in the pharmaceuticals in the previous fiscal year, etc.

①

（Million yen）

2017Revised

Forecast2016Actual YoY change

2017Initial

ForecastDifference

A B A-B C A-C

Real Estate 810 1,048 (238) 860 (50)

Other Segment 1,320 2,087 (767) 1,310 10

2,130 3,135 (1,005) 2,170 (40)

Pharmaceuticals 1,100 1,345 (245) 1,100 0

Real Estate 1,890 2,086 (196) 1,900 (10)

Other Segment 500 682 (182) 520 (20)

3,490 4,113 (623) 3,520 (30)

Pharmaceuticals 2,100 2,285 (185) 2,210 (110)

Other Segment 430 282 148 390 40

2,530 2,567 (37) 2,600 (70)

Capital expenditures

Depreciation

R&D Expenditures

３．Progress Report on “Katakura 2021”

13


Sustainable growth

(1) Fundamental Strategy

14

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2023

Katakura 2016 Katakura 2021

■ Positioning of this plan

Transform Katakura

into a Growing Business

Create new

businesses

➣ Aim to become No. 1 in targeted domains by meeting diversifying customer needs

➣ Build a stronger profit structure by reexamining our current businesses and shifting

resources to growing businesses

➣ Target opportunities in the markets of emerging countries

➣ Leverage synergies across our current businesses to create new businesses

➣ Supply innovative products and services by meeting people’s latent needs in order to

create growing businesses

➣ Use a long-term perspective to create activities that can become the new core businesses

of Katakura GroupBeloved

bicentennial company

Create new businesses

Transform Katakura into a Growing Business Structural

reform

Laying foundation to

become a beloved

bicentennial company

the 150th anniversary

Financial Results of 2017 2Q(2) Numerical Plan Net Sales and Operating Income by Segment

15

Katakura 2021Katakura 2016

（Million yen）

2017～2021

Plan

Real Estate 18,000

Other Segment 7,000

25,000

Real Estate 8,500

Pharmaceuticals 4,500

Other Segment 3,000

16,000

Pharmaceuticals 10,000

Other Segment 2,000

12,000

Capital expenditures

Depreciation

R&D Expenditures

＜5-year capital expenditures etc.＞

（Million yen）

2016 2017 2021

Actual Forecast Plan

Textiles 9,635 9,400 11,500

Pharmaceuticals 15,065 14,700 15,200

Machinery 9,412 10,300 13,000

Real Estate 10,188 10,300 10,800

Others 2,502 2,500 4,100

New businesses 124 200 2,000

46,927 47,400 56,600

（Million yen）

2016 2017 2021


Textiles (250) (100) 500

Pharmaceuticals 199 300 1,200

Machinery 88 50 400

Real Estate 3,176 3,400 4,000

Others (27) 0 200

New businesses (484) (300) 100

adjustments (1,216) (1,600) (1,200)

1,486 1,750 5,200

Net sales

Operating income


(2) Numerical PlanBusiness Foundation Supporting New Medium-term Management Plan

16

Complete structural reforms of unprofitable businesses by the end of

FY2018, taking downsizing or withdrawal into account

Expand business fields for further growth in continually growing businesses

Aim to create the group’s new core businesses in the strategic priority fields,

integrating management resources of each segment while actively using

alliances and M&A with other companies

①

②

③ Senior Care, Welfare and Health

Agriculture and Environment

Disaster prevention and Security

High value-added Fabric

New businesses in Saitama Shintoshin Area

Financial Results of 2017 2Q(3) Business Segment Reports Textiles

17

■ Strategic initiatives & Progress Report

■ Numerical Plan

Develop new national brands based on natural materials

Strengthen competitiveness by rebuilding functions

Strategic

initiatives

Progress

Report

New national brands

・ Introduced "Katakura Silk" brand entirely and

exclusively dedicated to silk

・ Expansion of sales of new "Care Cotton" basic skin

care product

Structural Reform of Business・ Shrinking low-profit margin products

・ Review of physical distribution expenses

・ Common operating system for 3 practical utility

clothing companies

Nitivy ALF™

＜Practical Clothing＞

Develop new high-functional materials and application of heat-resistant fibers

Strategic

initiatives

Progress

Report

Work on developing new varieties of alumina long fibers

Started study of a grand design for a manufacturing facility

＜Functional fibers＞

CARE COTTON

（Million yen）

2016 2017 2021 Progress


Net sales 9,635 9,400 11,500 82%

　Practical clothing 7,831 7,500 9,500 79%

　functional fibers 1,804 1,900 2,000 95%

Operating income (250) (100) 500 －

Operating income ratio －－ 4.3% －




18

(3) Business Segment Reports Textiles 【Topics】

■Premium line released (March 27)

New brand "Katakura Silk" on sale, pop-up sales at department stores nationwide

Financial Results of 2017 2Q(3) Business Segment Reports Pharmaceuticals

19


Progress

Report

Enter into a neighboring field of kidney and dialysis

Focus on generic drugs

Efficient R&D of new drugs by using licensing methods

Strengthen successions and co-promotions (sales alliances)

■ Numerical Plan

Strategic

initiatives

Engaging with sales growth of Bisono Tape・ Addition of chronic atrial fibrillation indication, improvement of

formulation (Application for approval is planned in 2018)

Expansion of range of items - mainly for generic products・ Applications for approval of 3 items in cardiovascular field, kidney and

dialysis fields are underway・ Applications for multiple items from next term are in progress

Reviewing the organizational structure to respond to regional strategy/product strategy transformation

Hypertension treatment drug” Bisono Tape “

（Sales started in September 2013）

A treatment for arrhythmia ” Cibenol ” etc.

（Million yen）

2016 2017 2021 Progress


Net sales 15,065 14,700 15,200 97%

Operating income 199 300 1,200 25%

Operating income ratio 1.3% 2.0% 7.9% －

　R&D Expenditures 2,285 2,100 10,000 (5 years)

Financial Results of 2017 2Q(3) Business Segment Reports Machinery

20


Progress

Report

Improve functions of fire engines and expand a neighboring field

Expands the Vowcan series and enter into the disaster prevention field

Develops specially-equipped vehicles using outfitting technologies

Advance into overseas markets mainly in Asia

■ Numerical Plan

Strategic

initiatives

Expand business

・ Established a new company providing maintenance services to power

companies (April) We are considering business collaborations with other

companies so as to be able to expand into peripheral fields

Exhibited at the "66th Tone River Water System Association· Comprehensive Flood Control Exercise"

The Large-capacity submersible pump system “Vowcan”

Fire truck with a ladder

（Million yen）

2016 2017 2021 Progress


Net sales 9,412 10,300 13,000 79%

Operating income 88 50 400 13%


Disaster prevention and safety

Financial Results of 2017 2Q(3) Business Segment Reports Real Estate

21


Progress

Report

Starts Stage 3 development Expand businesses from the

standpoint of community creation

■ Numerical Plan

Strategic

initiatives

Stage 3 development

・ Considering a development plan for the

entire site of the Saitama Shintoshin Area

Measures to enhancing the value of

the area

・ Cooperation with peripheral businesses,

particularly the "Saitama Shintoshin

Development Promotion Council"

＜Saitama Shintoshin community creation＞＜Acquisition of new land for development＞

Searching for real estate properties, mainly concentrating on commercial development (shopping centers, etc.) in the Tokyo metropolitan area (including Saitama Shintoshin), and business development (office buildings, etc.)

Investment in new acquisition: 10,000 million yen（2017-2021）

Acquisition of new land for

development

Strategic

initiatives

Progress

Report

COCOON City “ COCOON2 “（Opened on April , 2015 ）

（Million yen）

2016 2017 2021 Progress


Net sales 10,188 10,300 10,800 95%

Operating income 3,176 3,400 4,000 85%


　Depreciation 2,086 1,890 8,500 (5 years)

Financial Results of 2017 2Q(3) Business Segment Reports Real Estate

22

■ Saitama Shintoshin Ekimae Company-owned LandThe entire company-owned land : About 147,000㎡

(The area of each sector does not include public streets.)

a

b

c d

e

ｈ

ｆ

gi

j

kl

Japan Mint ・Museum Saitama Shintoshin Station

Saitama Super Arena

●

JR Saitama Shintoshin building

●

Land Axis Tower

●

Saitama Red Cross HospitalSaitama Children's Medical Center

●

NTT DOCOMO Saitama building

●

Government office complex

● ●

Omiya Police Station（scheduled for fall 2017）

Stage 1 development

Land areaAbout 33,000㎡

Stage 2 development

Land areaAbout 68,000㎡

a. COCOON1 b. COCOON2 c. COCOON3 d. Park side building e. Lexus Saitama Shintoshin f. Volkswagen Saitama Shintoshin g. cocoon athletics

h. Garden Hills Geihinkan i. COCOON City Housing exhibition space j. Office building k. Nursing care facility [Nichii Gakkan] l. convenience store


Recruiting members for Yoga Studio & Bouldering (Rock Climbing) Gym which

opens for business in September

23

(3) Business Segment Reports Real Estate 【Topics】

■ Facility Outline

*The picture is an image

Housing-type fee-based nursing home opened in July

・ Saitama prefecture's first indoor & outdoor hybrid sports club・ Offering services such as yoga, bouldering (rock climbing),

run & walk, café, etc.

・ Revenue form： Usage charge revenue

・ Facility name： cocoon athletics

・ Operator： BEACH TOWN CORPORATION, Primary contractor： Katakura Industries Co., Ltd.

■ Facility Outline

・ Revenue form： Building rental (52 rooms in total)

・ Facility name： Granda Inokashira Park

・ Operator： Benesse Style Care Co., Ltd.

・ Developed former site (about 2,670 m²) of company-owned housing in Mitaka City, Tokyo

New businesses in Saitama Shintoshin Area Senior Care, Welfare and Health

Financial Results of 2017 2Q(3) Business Segment Reports New businesses

24

Two senior day care service

facilities in Tokyo

”Kinumitsu“cosmeticsFacial soap

Cleansing oilLotion

All in one gel

Low-potassium lettuce

Cauliflower fungus

“Hanaka”

Expand the business of nursing care services and develop and expand sales of equipment for senior care and welfare

Expand the product lineup in cosmetics field and advance into healthy food field

Develop and expand sales of high value-added vegetables and establish a mass production system at plant factories

■ Numerical Plan

Progress

Report

Strategic

initiatives


Making every effort toward early monetization

Striving towards expansion of business scale

・ “e-anza" new model released for sale

・ Expanding product lineup and sales channels

（Million yen）

2016 2017 2021 Progress


Net sales 124 200 2,000 10%

Operating income (484) (300) 100 －

Operating income ratio －－ 5.0% －

Senior Care, Welfare and Health

Agriculture and Environment

Sale of toilet seats designed for ostomates


Released “e-anza" wide-front toilet seat new model (July 5), Introduction at all stores of a major drugstore chain decided on

25

(3) Business Segment Reports New businesses 【Topics】

Welcia Pharmacy, Nihonbashi Store 1/ B.B.ON Nihonbashi

Introduction examples（As of June 2017）

＜Hospitals＞・ The University of Tokyo Hospital (Tokyo)・ Totsuka Kyouritsu Daini Hospital (Kanagawa)・ Hidaka Hospital (Gunma)

＜Parks＞・ Higashimatsudo Yuinohana Park (Chiba)＜Commercial facilities＞

・ COCOON City (Saitama, Operator : Katakura Industries Co., Ltd.)

・ atre Omori (Tokyo, Operator : Atré Co. Ltd.)・ Tradepia Odaiba (Tokyo, Operator : Ichigo)・ Matsudo Nanbu Wholesale Market (Chiba,

Operator : Ichigo)・ Miyako City (Miyazaki, Operator : Ichigo)

■ Introduction proceeding after the release in November 2015

■Product feature

image Huge burden on legs and hips in half-

rising posture.

Financial Results of 2017 2Q(4) Approach to ESG (*)

26(*) Environment, Social and Governance

Held “Saitama Uchimizu (watering) Big Operation 2017" in co-sponsorship

with civic groups and administrative organizations in COCOON City

Uchimizu at the COCOON Square

About 300 people participated in the event

【 Environment＆Social 】

４．Dividends and Dividend Policy

27

Financial Results of 2017 2QDividends and Dividend Policy

Dividend per Share 2016 Dividend

Ordinary dividend ¥10

28

＜Dividend Policy＞

Dividend per Share 2017 Dividend

Forecast

Ordinary dividend ¥10

8

10 10 10 10 10 10 10 10 10 10 10

1,444 1,887

1,015

(781)

3,985

1,772

701 1,001 268 226

1,691 1,200

＜ Dividends and Net Income ＞

Dividends（yen） Net income（Million yen）

The basic policy for allocating earnings is to pay a consistent and stable dividend to shareholders while taking into account results of operations as well as the need to fund upcoming business operations and maintain sufficient retained earnings.

Supplementary Information

29

Financial Results of 2017 2Q《Supplementary Information①》 The Source of Katakura’s Diversification

30

Raw silk Production Silk thread research Manufacture of silk reeling machines

Thread factories

Founded １８７３

Established １９２０

Silk thread production Raw silk Ownership of Tomioka Silk Mill

1939-2005 (66 years)

Carrying on the tradition of raw silk production

Innovating originating from research to create outstanding silk products

Utilizing know-how for the internal development of manufacturing equipment

Utilizing the former sites of thread factories

Textiles Pharmaceuticals Machinery Real Estate

ApparelManufacture and sale of underwear and socks

Ogran Japan Co., Ltd. Manufacture and sale of casual innerwear

Kafulas Co., Ltd.Manufacture and sale of foundation undergarments

Toa Eiyo Ltd.Manufacture and sale of prescription drugs

MechatronicsManufacture and sale of automotive parts and other products

Nihon Kikai Kogyo Co., Ltd.Manufacture and sale of fire engines

Katakura Machinery Industries Co., Ltd.Manufacture and sale of agricultural machinery

Commercial FacilitiesOperation of shopping centers,

real estate leasing

Real Estate Development BusinessDevelopment and use of company-owned land

Others

Bioscience Research CenterProduction and sale of insect pollinators and other products

Katakura Caron Service Corp.Building cleaning and maintenance services

Retailing BusinessOperation of home improvement centers

Others

Nitivy Co., Ltd.Manufacture and sale of functional fibers

Financial Results of 2017 2Q《Supplementary Information②》 The Business Activities of Katakura Group

31

Pharmaceuticals Machinery

Real Estate Others

Textiles

Apparel Ogran Japan Co., Ltd. Kafulas Co., Ltd. Nitivy Co., Ltd.

Toa Eiyo Ltd. Mechatronics Nihon Kikai Kogyo Co., Ltd.Katakura Machinery Industries Co., Ltd.

Commercial Facilities

Real Estate Development Retailing

Bioscience Research Center

Katakura Caron Service Corp.

Silk innerwearNursing care underwear

Licensed products Support undergarments Alumina fiber yarn(fire resistant)

Three-way valve

Vibration bubbling cleanser

Fire engines

Two-wheel power tiller

Tokyo Square Garden COCOON City

New Life Katakura Mulberry Garden

Cross-fertilization honeybee products

Building maintenance

Fire truck with a ladder


＜Disclaimer ＞

Sales and earnings forecasts and other forward-looking statements in this document are based on the economic

forecast and other current assumptions. These statements are not guarantees or promises regarding future

performance. Furthermore, forecasts may be revised at any time without prior notice.

Katakura has exercised care to be certain that all information in this document is correct. However, Katakura

assumes no responsibility whatsoever for any errors in this information.

＜Contact information＞

Hideaki Mori (Manager) / Nobuyuki Kikuchi

PR・IR Office, Corporate Planning Dept.

Katakura Industries Co., Ltd.

URL: http://www.katakura.co.jp/

Address: 6-4 Akashi-cho, Chuo-ku, Tokyo 104-8312

Tel : 03-6832-0223

Fax: 03-6832-0282

World Heritage Site "Tomioka Silk Mill"

Special WEB page "history walked the Katakura and Tomioka Silk Mill"

http://www.katakura.co.jp/tomioka.htm

32

http://www.katakura.co.jp/tomioka.htm

financial results of 2017 2nd quarterfinancial results of 2017 2q (2) numerical plan net sales and...

Documents